Concepedia

Kang‐Seo Park

KP

15

Publications

535

Citations

14

H-Index

2009

Active since

Affiliations

Asan Medical Center(Current)

University of Ulsan

Ulsan College

National Cancer Institute

Korea Research Institute of Chemical Technology

Kang‐Seo Park is an author at Asan Medical Center specializing in cell biology, medicine, and tumor biology.

Top concepts

Publications per year

2009–2020

15

Publications

15

Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer

Kang‐Seo Park, Hyun‐Kyoung Kim, Jung-Hwa Lee et al. · Journal of Cancer Research and Clinical Oncology · 2009 · 107 citations · Full text

, , +9

Differences in the molecular signatures of mucosal-associated invariant T cells and conventional T cells

Daeui Park, Hong Gi Kim, Mi‐Ok Kim et al. · Scientific Reports · 2019 · 47 citations · Full text

The HSP90 inhibitor, NVP-AUY922, sensitizes KRAS-mutant non-small cell lung cancer with intrinsic resistance to MEK inhibitor, trametinib

Kang‐Seo Park, Bora Oh, Mi-Hee Lee et al. · Cancer Letters · 2015 · 41 citations

, , +7

Trichostatin A Sensitizes Hepatocellular Carcinoma Cells to Enhanced NK Cell-mediated Killing by Regulating Immune-related Genes

Sangsu Shin, Mi‐Ok Kim, Seon‐Jin Lee et al. · Cancer Genomics & Proteomics · 2017 · 40 citations · Full text

Blockade of CCL2 expression overcomes intrinsic PD-1/PD-L1 inhibitor-resistance in transglutaminase 2-induced PD-L1 positive triple negative breast cancer.

Junyoung Choi, Hee Jin Lee, Shinkyo Yoon et al. · PubMed · 2020 · 36 citations · Full text

, , +18

Rows per page

1–5 of 15